Inventor

Isao Kawamoto

Inventor
Hiratsuka, JP

Overview

49→
Patents
1976–2006
Patent span
Chemistry
Primary field (CPC C)

Patents· 49 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds17%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
C12NMicroorganisms or enzymes10%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms9%
A61KPreparations for medical, dental or toiletry purposes7%
C07HSugars7%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
C07CAcyclic or carbocyclic compounds4%
C07KPeptides3%
PatentTitleYear
7,041,660'Crystalline 1-methylcarbapenem derivatives'20066,924,279'Crystalline 1-methylcarbapenem derivatives'20056,642,355'Endothelin-antagonizing peptide'20036,194,195'Strains of streptomyces producing endothelin antagonistic peptides'20016,180,621'Method and treatment using 1-methylcarbapenem derivatives as an anti-helicobacter pylori agent'20016,090,802'1- Methylcarbapenem derivatives'20005,977,097'1-methylcarbapenem derivatives'19995,866,564'Carbapenem derivatives, their preparation and their use as antibiotics'19995,712,267'Carbapenem derivatives, their preparation and their use as antibiotics'19985,639,860'Endothelin-antagonizing peptide'19975,478,733'Process for producing L-alanine by fermentation with arthrobacter'19955,424,306'Crystalline carbapenem derivative'19955,420,119'Carbapenem derivatives having antibiotic activity, their preparation and their use'19955,310,735'Carbapenem derivatives having antibiotic activity, their preparation and their use'19945,252,470'D-amidase and process for producing D-.alpha.-alanine and/or L-.alpha.-alanineamide'19935,242,914'2-(heterocyclylthio) carbapenem derivatives, their preparation and their use as antibiotics'19935,223,637'KS-506 compounds'19935,142,096'2,4-dihydroxy-3,5,6-trimethylbenzoic acid compounds'19925,132,112'HS-142-1 compounds'19925,130,240'Process for producing D-alpha-alanine and/or L-alpha-alanineamide by Arthrobacter sp'19925,104,867'2-(heterocyclylthio)carbapenem derivatives, their preparation and their use as antibiotics'19925,101,038'Novel substance DC 113 and production thereof'19925,082,857'Chemical compound'19925,081,264'Bioxanthracene derivatives'19925,079,232'Compound KS-505 useful for improving cerebral function'19925,066,817'DC115A compounds produced by streptomyces sp.'19915,011,854'Hydroxamic acid derivatives and use thereof in combatting lipoxygenase-mediated diseases'19914,990,693'Novel substances KS-504a, KS-504b, KS-504d and KS-504e and process for their preparation'19914,983,775'Novel substances KS-504a, KS-504b, KS-504d and KS-504e and process for their preparation'19914,935,415'UCN-01 and process for production thereof'19904,923,990'Pyrindamycins A and B and duocarmycin A antibiotics derived from certain streptomyces culture'19904,914,198'Novel substance UCY1003 and process for preparing the same'19904,912,132'Novel substances KS-504a, KS-504b, KS-504d and KS-504e and process for their preparation'19904,894,385'Imidazole derivatives as inhibitors of TXA.sub.2 synthesis'19904,868,159'Novel substances KS-501 and KS-502 and process for their preparation'19894,771,046'Carbapenem derivatives'19884,692,310'Substance K-259-2 and a process for producing the same'19874,683,220'Novel physiologically active substances K-26, a process for preparation thereof and a pharmaceutical composition containing the same'19874,593,097'Phenazine carboxylic acid derivatives and a process for production thereof'19864,522,812'Novel physiologically active substance K-4, a process for preparation thereof and a pharmaceutical composition containing the same'19854,421,758'Anti-microbial diazole derivatives'19834,316,957'Process for the production of 7-deazaadenosine and 7-deazainosine'19824,162,305'Antibiotic XK-99 and process for production thereof'19794,045,610'Antibiotics designated XK-88 series'19774,045,298'Antibiotic XK-62-2 and process for production thereof'19773,976,768'Fortimicin A'19763,951,661'Silver halide emulsion containing an arylphosphonium salt as antifoggant'19763,939,043'Antibiotics designated XK-88 series and process for production thereof'19763,931,400'Fortimicin B and process for production thereof'1976

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1976–1982Patents assigned to ABBOTT LAB (7)· patent assignee history
1976Patents assigned to KONISHIROKU PHOTO IND (1)· patent assignee history
1976–1977Based in Machida, JP· patent location history
1979–2003Based in Hiratsuka, JP· patent location history
1983–2006Patents assigned to SANKYO CO (15)· patent assignee history
1983–1993Based in Hiromachi, JP· patent location history
1985–2003Patents assigned to KYOWA HAKKO KOGYO KK (24)· patent assignee history
1988–2006Based in Tokyo, JP· patent location history
1990–1992Based in Kanagawa, JP· patent location history
1992Patents assigned to KYOWA HAKKO KABUSHIKI KAISHA (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
KYOWA HAKKO KOGYO KK241985–2003
SANKYO CO151983–2006
ABBOTT LAB71976–1982
KONISHIROKU PHOTO IND11976
KYOWA HAKKO KABUSHIKI KAISHA11992
Locations
LocationPatentsSpan
Hiratsuka, JP211979–2003
Tokyo, JP121988–2006
Kanagawa, JP71990–1992
Machida, JP51976–1977
Hiromachi, JP31983–1993